MEXIDOL® in the Rehabilitation Treatment of Patients With Acute Cerebral Failure

Clinical trial NCT06221826 · COMPLETED

Trial details

NCT number: NCT06221826
Sponsor: Pharmasoft
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Ischemic Stroke, Acute

Start date: 2023-04-17
Primary completion: 2023-09-12
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.